ACC 58th Annual Scientific Session, 28-31 March, 2009, Orlando—Peter Goodwin hears from Germano Di Sciascio of the Campus Bio-Medico University of Rome latest data on mortality from the Atorvastatin for Reduction of Myocardial Infarction during Angioplasty—ARMYDA—study—which looked at preloading patients with Atorvastatin before PCI.

Share